A1M Pharma announced that the company has appointed Tobias Larsson Agervald as its new chief medical officer. Tobias Larsson Agervald is an associated professor and specialist in internal medicine and nephrology with extensive experience in global research and development of pharmaceuticals in both early and later clinical stages. He will assume the position on December 1,2018. As CMO,Tobias Larsson Agervald will be responsible for the overall medical strategy as well as designing, implementing and conducting the company's clinical development program.